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Abstract
The existence of endogenous neural progenitors in the nigrostriatal system could represent a powerful tool for restorative
therapies in Parkinson’s disease. Sox-2 is a transcription factor expressed in pluripotent and adult stem cells, including
neural progenitors. In the adult brain Sox-2 is expressed in the neurogenic niches. There is also widespread expression of
Sox-2 in other brain regions, although the neurogenic potential outside the niches is uncertain. Here, we analyzed the
presence of Sox-2+ cells in the adult primate (Macaca fascicularis) brain in naı¨ve animals (N = 3) and in animals exposed to
systemic administration of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine to render them parkinsonian (N = 8). Animals
received bromodeoxyuridine (100 mg/kg once a day during five consecutive days) to label proliferating cells and their
progeny. Using confocal and electron microscopy we analyzed the Sox-2+ cell population in the nigrostriatal system and
investigated changes in the number, proliferation and neurogenic potential of Sox-2+ cells, in control conditions and at two
time points after MPTP administration. We found Sox-2+ cells with self-renewal capacity in both the striatum and the
substantia nigra. Importantly, only in the striatum Sox-2+ was expressed in some calretinin+ neurons. MPTP administration
led to an increase in the proliferation of striatal Sox-2+ cells and to an acute, concomitant decrease in the percentage of Sox-
2+/calretinin+ neurons, which recovered by 18 months. Given their potential capacity to differentiate into neurons and their
responsiveness to dopamine neurotoxic insults, striatal Sox-2+ cells represent good candidates to harness endogenous
repair mechanisms for regenerative approaches in Parkinson’s disease.
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Introduction
Parkinson’s disease is a neurodegenerative disorder character-
ized by a progressive degeneration of the nigral dopamine
neurons. The neuronal loss produces a reduction of striatal levels
of dopamine resulting in motor dysfunction. Pharmacological
restoration of dopamine levels alleviates the cardinal symptoms of
the disorder but several motor complications appear with chronic
replacement treatment. This fact has led to a search for alternative
treatments, including cellular therapy. In addition to ethical and
logistic problems, fetal cell transplantation has been only
moderately successful and, in some instances, complicated by
adverse effects [1,2,3]. An attractive alternative would be to direct
the neurogenic potential of the adult human brain to restore the
nigrostriatal function. In this regard, it is well established that
neurogenesis persists in the adult mammalian brain in the
subventricular zone (SVZ) of the lateral ventricles and the
subgranular zone (SGZ) of the dentate gyrus (for review see [4]).
Whether adult neurogenesis takes place in other regions [5,6,7] is
less clear. In rodents, cells with neurogenic potential have been
isolated from the cortex, striatum, spinal cord and substantia nigra
(SN) [8,9,10,11,12,13]. These cells have self-renewal capacity
in vitro and are able to give rise to both neuronal and glial lineages
[8,9,10,11,12,13]. Interestingly, a population of actively dividing
progenitor cells has been described in the SN of the adult rat brain
[8]. These cells did not give rise to neurons in vivo but acquired the
capacity to generate new neurons after being transplanted into the
hippocampus, a neurogenic area [8]. Moreover, it has been
reported that local progenitors generate new neurons in the
striatum of adult rat and rabbit [14,15]. Finally, an increase in
neurons has been found to take place in the striatum and cortex in
response to certain insults in rodents and primates
[16,17,18,19,20,21]. Together, these studies suggest that, in these
regions, there are quiescent neural precursors capable of
generating new neurons when activated by specific factors.
Sox-2 is a sex-determining region Y (SRY) - box2 - related
transcription factor expressed during development in self-renewing
and multipotent neuroepithelial stem cells [22,23]. Sox-2 main-
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tains neural progenitor identity and inhibits neuronal differenti-
ation by repressing basic helix-loop-helix (bHLH) proneurogenic
factors [24,25,26]. Undifferentiated and multipotent cells express
Sox-2 and its expression needs to be down-regulated for the cells to
acquire mature phenotypes [24,25]. Sox-2+ cells isolated from the
adult mouse brain form spheres in vitro and can differentiate into
neurons, astrocytes and oligodendrocytes by changing culture
conditions [27]. Genetic lineage tracing and transplantation
experiments in mice have shown that Sox-2-expressing cells
continuously give rise to mature cells in the dentate gyrus [28]. In
other organs, Sox-2+ cells display self-renewal and differentiation
potential to maintain tissue homeostasis [29]. Sox-2 is considered a
marker of quiescent and amplifying progenitors in the neurogenic
niches [30,31,32], but it is also expressed in non-neurogenic areas
of the rodent brain such as the cortex and the striatum [31].
However, according to that study [31] Sox-2+ cells in non-
neurogenic areas of the rodent brain do not divide and they all
express glial fibrillary acidic protein (GFAP). Nevertheless, in
another recent study, new striatal neurons could be generated
from Sox-2+ precursors in a lesion model of striatal degeneration
[33].
Expression of Sox-2 in cells of the SVZ and the SGZ of non-
human primates has been previously reported [34,35] but there
are no available data concerning its expression in non-neurogenic
regions of the adult brain. In this study, we have analyzed the
expression of Sox-2 in the nigrostriatal system in macaques
(Macaca fascicularis), to examine their presence in these structures,
their capability to generate new neurons and their response to
neurotoxicity and dopamine loss in a model of Parkinson’s disease.
Materials and Methods
Animals
Eleven adult (4–5 years), male monkeys (Macaca fascicularis)
weighing 3–5 kg were included in the study. They were housed
under standard conditions of air exchange (16 l/min), humidity
(50%), and light/night cycles (8 a.m. to 8 p.m.), and were fed fresh
fruit and commercial pellets, with free access to water. Their
health was monitored by the attending veterinarian, in consistency
with the recommendations of the Weatherall Report. The animals
were euthanized following deep anaesthesia, and all efforts were
made to minimize suffering. Experimental protocol was in
accordance with the European Communities Council Directive
of 24 November 1986 (86/609/EEC) and was approved by the
Ethics Committee for Animal Experimentation of the University
of Navarra.
Eight monkeys received a weekly intravenous injection of 1-
methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) (Sigma) (0.
25 mg/Kg) during eight consecutive weeks. The cumulative
MPTP dose was 2 mg/Kg. Three animals were not treated with
MPTP and served as controls. The 3 control animals and 4
MPTP-treated animals were given an intraperitoneal injection of
bromodeoxyuridine (BrdU) (Sigma), 100 mg/Kg/day for 5
consecutive days starting one week after the last MPTP injection,
and were sacrificed 3 months later (short-term MPTP group n= 4,
and control group n=3). The 3 months interval after BrdU was
chosen based on previous works [36,37] that have established that
this period is necessary for detecting newborn and mature neurons
in the monkey brain. The other 4 MPTP treated animals were
sacrificed 18 months after the last MPTP injection (long-term
MPTP group n=4). The 18 months interval was chosen to assess
the specific effect of the reduction in dopamine levels at a chronic
stage once the reaction to the toxic insult is over.
Immunohistochemistry
Animals were deeply anesthetized and transcardially perfused
with saline followed by 4% paraformaldehyde in phosphate-
buffered saline (PBS). Brains were post-fixed overnight in the same
fixative at 4uC and cryoprotected in a 30% sucrose solution in
PBS. Coronal sections (40 mm thick) were cut on a freezing
microtome, collected in anti-freezing solution (0.125 M PBS, 15%
dimethylsulfoxide, and 15% glycerin) and stored at -20uC for later
analysis. All analyses were carried out on the right hemisphere. All
immunohistochemical assays were performed in free-floating
sections. Rat embryonic tissue was used as a positive control for
Sox-2. Omission of the primary antibody served as a negative
control.
Coronal sections containing striatum, SVZ, SN pars compacta
and dentate gyrus, were processed for immunohistochemical
studies. Sections were washed with PBS, treated with 3% H2O2
with 10% methanol for 15 minutes, blocked for nonspecific
binding with donkey serum (1/20) and incubated with an
antibody raised against Sox-2 (goat IgG; 1/200; Neuromics) or
tyrosine hydroxylase (TH) (1/1000; Millipore) for 24 hours at
4uC in PBS containing 0.1% Triton X-100 (Sigma Chemical
Co). Subsequently, they were incubated with a biotinylated anti-
goat secondary antibody (1/500, Jackson Immunoresearch) for
30 minutes and processed with an avidin-biotin complex kit
(Vectastain ABC kit; Vector Laboratories) for 30 minutes at
room temperature. The chromogen solution was 39, 39-diami-
nobenzidine (DAB) with H2O2 (DAB kit, Vector Laboratories).
Sections were rinsed in distilled water and 0.01 M PBS, mounted
on gelatin-coated slides and air-dried, counterstained with Nissl,
coverslipped using DPX (BDH) and examined by light micros-
copy.
Table 1. List of the secondary antibodies used in the present study.






-Donkey anti-goat 488 Donkey Molecular probes A11055 1:500
-Donkey anti-goat 568 Donkey Molecular probes A11057 1:500
-Donkey anti-goat 633 Donkey Molecular probes A21082 1:500
-Donkey anti-mouse 488 Donkey Molecular probes A21209 1:500
-Donkey anti-rabbit 555 Donkey Molecular probes A31572 1:500
-Donkey anti-rabbit 647 Donkey Molecular probes A31573 1:500
doi:10.1371/journal.pone.0066377.t001
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Figure 1. Expression of Sox-2 in neurogenic niches and the nigrostriatal system in the adult primate brain. A. Schematic outline of the
anatomical borders for the neurogenic niches as defined for the study. B. Confocal images of Sox-2+ cells in the neurogenic niches and nigrostriatal
regions. Sox-2+ cells were evenly distributed throughout the brain parenchyma including the striatum and the SNpc. C. Stereological estimation of
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Sox-2+ cells revealed that the density of Sox-2+ cells was higher in the SNpc than in the striatum and lower in both regions than in the neurogenic
niches (data shown for SGZ). Data represent median and quartiles, N = 3, *p#0.05. Scale bar = 20 mm. Abbreviations: Substantia nigra pars compacta:
SNpc; subgranular zone: SGZ.
doi:10.1371/journal.pone.0066377.g001
Figure 2. Characterization of Sox-2+ cells in the neurogenic niches. Confocal images showing Sox-2+ cells in the neurogenic niches.
Representation of Sox-2+ cells in the SVZ that incorporate BrdU and Sox-2+ cells in the dentate gyrus of the hippocampus that co-express Ki67.
Examples of Sox-2+/DCX+ in the SVZ and Sox-2+/GFAP+ in the SGL of the dentate gyrus. There were no differences between the control and MPTP
treated animals. Scale bar = 50 mm. Abbreviations: subventricular zone: SVZ; doublecortin: DCX; subgranular layer: SGL; 1-methyl-4-phenyl-1,2,3,6
tetrahydropyridine: MPTP.
doi:10.1371/journal.pone.0066377.g002
MPTP Modulates Neurogenesis in Primate Striatum
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e66377
MPTP Modulates Neurogenesis in Primate Striatum
PLOS ONE | www.plosone.org 5 June 2013 | Volume 8 | Issue 6 | e66377
Immunofluorescence Techniques
Double and triple-immunofluorescence techniques were per-
formed in the SVZ, anterior striatum, dentate gyrus and SN
sections to detect cells double-labeled with Sox-2 and markers of
cell proliferation and differentiation. The primary antibodies used
were goat anti-Sox-2 (1/200; Neuromics and R&D Systems); rat
anti-BrdU (1/100; Abcam); rabbit anti-Ki67 (prediluted; Master
Diagnostica); rabbit anti-GFAP (1/500; Dako); guinea pig anti-
doublecortin (DCX) (1/100; Millipore); rabbit anti-calretinin (CR)
(1/200; Millipore); mouse anti-NeuN (1/500; Millipore); mouse
anti-TH (1/1000; Millipore); rabbit anti-TH (1/1000; Millipore)
and mouse anti-glutamic acid decarboxylase 67 (GAD-67) (1/500;
Millipore). For BrdU+ cell detection, sections were pretreated with
2 N hydrochloric acid at 37uC for 30 minutes and 0.1 M boric
acid at room temperature for 15 minutes. For Ki-67+ cell
detection, sections were pretreated with 10 mM citrate buffer
pH 6 at 80uC for 30 min. Secondary antibodies are listed in
Table 1.
A standard immunohistochemical procedure was followed.
After incubation overnight at 4uC with a mixture of primary
antibodies in PBS containing 0.1% Triton X-100, sections were
washed 3 times in PBS for 5 minutes and incubated with the
fluorophore-conjugated specific secondary antibodies for 2 hours
at room temperature. Some sections were incubated with To-pro3
for 10 minutes. All sections were mounted with 1% PBS-Glycerol
and examined under a confocal microscope (LSM 510 Meta,
Zeiss).
Electron Microscopy
To analyze the ultrastructural features of Sox-2+ cells we used a
pre-embedding DAB immuno-staining (as above) and a pre-
embedding immuno-gold technique. For immuno-gold technique,
coronal sections (40 mm) were washed in 0.1 M PBS and freeze-
thawed (3x) in methyl-butane. Sections were washed in PBS,
blocked in 0.3% bovine serum albumin-C (BSA) and incubated in
primary goat anti-Sox-2 antibody (AF2018, R&D System) 1/50 in
blocked buffer for 3 days at 4uC. Sections were washed in PBS,
blocked in 0.5% BSA and 0.1% fish gelatin during 1 hour,
incubated in colloidal gold conjugated rabbit anti-goat secondary
antibody (1/50) for 24 hours. Silver enhancement was performed
and washed again in 2% sodium acetate, washed with gold
chloride 0.05%, washed in sodium thiosulfate 0.3% then washed
in PBS and post-fixed in 2% glutaraldehyde (30 min) [38].
Sections were contrasted with 1% osmium and 7% glucose and
embedded in araldite. Semi-thin 1.5 mm sections were prepared
and the section(s) of interest were selected under light microscopy
and re-embedded for ultra-thin sectioning at 70 nm. Photomicro-
graphs were obtained under a transmission electron microscope
(FEI Tecnai G2 Spirit BioTwin) using a digital camera (Morada,
Soft Imaging System, Olympus).
Quantifications
The estimation of the total number of TH+ neurons in the SN
was done by stereology using an Olympus BX-51 microscope
hard-coupled to a Prior H128 computer-controlled x-y-z motor-
ized stage, a DP70 camera and a computer equipped with
Olympus CAST system version 2.0 (Olympus, Albertslund). The
analyzed regions were outlined under a low magnification
(UPlanApo 4x/0.16, Olympus) objective at all levels in the
rostrocaudal axis (6–7 sections per animal). A counting frame was
randomly superimposed on the image and neurons were
systematically sampled using a 60x lens (Plan Apo N 60x/1.42
oil, Olympus) with the nucleolus used as the sampling unit. The
sampling frequency was chosen by adjusting the xy-axis step length
so that up to 200 cells were counted in each specimen.
In the striatum, only TH+ structures with a visible Nissl-labeled
nucleus were counted, to ensure that they were indeed cells. Cell
counting was undertaken using bright-field microscopy under a
206objective lens (Olympus BX51) in four brain sections, taken at
similar anatomical levels among animals of the anterior striatum
(AP: from +1 to +5 mm according to the atlas of Martin-Bowden
[39]. In each animal, cell density (number of TH+ neurons per
cm2) was calculated by dividing the total number of TH+ neurons
by the area.
Estimation of Sox-2+ cellular density was done by stereology in
the striatum, SN and SGZ of the dentate gyrus as described above
for TH+ neurons but cells were sampled using a 20x lens (PlanApo
20x/0.70, Olympus). In each animal, the Sox-2 cell density was
obtained by dividing the total number of Sox-2+ cells by the total
analyzed area (mm2).
Sox-2+/BrdU+ cells in the striatum were counted using a laser
scanning confocal microscope (LSM 510/Meta, Zeiss, Germany)
under a 20x objective lens in three brain sections, taken at
equivalent anatomical levels of the anterior striatum (AP: from +1
to +5 mm according to the atlas of Martin-Bowden, (1996) [39].
In each animal, cell density (number of Sox+/BrdU+ cells per
mm2) was calculated by dividing the total number of Sox+/BrdU+
cells by the surveyed area.
To calculate the percentage of CR+ cells that expressed Sox-2
we used three matched sections of the pre-commisural striatum of
each animal (AP: from +1 to +5 mm according to the atlas of
Martin-Bowden, (1996) [39]). At least 500 CR+ cells distributed
within the entire section were analyzed for each animal, and
double-labeled cells were identified using a confocal microscope.
For statistical comparisons between groups we used the number of
CR+ cells that expressed Sox-2 over the total number of CR+ cells
(%).
Western Blot Analysis
Dissection of the anterior striatum was carried out in ten 40 mm
sections for each animal. For protein extraction from formalin
fixed tissues,100 mL of 20 mM Tris-HCl buffer pH 9 containing
2% SDS was added and then they were heated at 100uC on a heat
block (VWR Scientific Products) for 20 min, and at 60uC in a
heater (Indelab) for 2 hours [40]. Samples (10 mg) were separated
Figure 3. Characterization of Sox-2+ cells in the substantia nigra and striatum of naı¨ve adult primates. A. Confocal images show BrdU
incorporation (yellow arrowhead), and co-expression of Ki67 (yellow arrowhead) in Sox-2+ cells in the parenchyma of the SNpc. Sox-2+ cells were
never positive for TH. Some Sox-2+ cells corresponded to satellite glial cells sitting on TH+ neurons, as shown in the merged panels (blue arrowheads).
Many Sox-2+ cells expressed GFAP (yellow arrowhead) but there were also Sox-2+/GFAP– (blue arrowhead) that may correspond to amplifying
progenitors. There was no Sox-2+/CR+ co-expression in any cell in this region. Scale bar = 20 mm. B. In the striatal parenchyma some Sox2+ cell
showed BrdU incorporation (yellow arrowhead) and co-expressed Ki67 (yellow arrowhead). Most Sox-2+ striatal cells expressed GFAP (yellow
arrowhead) but there were also Sox-2+/GFAP– (blue arrowhead). Some CR+ striatal neurons showed nuclear expression of Sox-2 (yellow arrowhead)
while others did not (blue arrowhead). Scale bars = 10 mm. Abbreviations: Substantia nigra pars compacta: SNpc; tyrosine hydroxylase: TH; glial
fibrillary acidic protein: GFAP; calretinin: CR.
doi:10.1371/journal.pone.0066377.g003
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Figure 4. Phenotype of Sox-2 striatal cells in naı¨ve adult primates. A. Schematic drawing of the distribution of Sox-2+/CR+ neurons in control
animals. Note that they are located close to the dorsolateral border of the striatum; the inmunofluorescence images show the co-localization (yellow
arrowhead) of Sox-2 (red) and CR (green). An orthogonal reconstruction is shown in supplemental Fig. S3A. B. TH+ striatal cells never co-localized
with BrdU and the vast majority of CR+ striatal cells were BrdU–. Scale bar = 20 mm. C. Detailed analysis of BrdU incorporation in the striatum showed
that there were some Sox-2+/GFAP+/BrdU+ cells (yellow arrowhead) but the majority were negative for this glial marker (white arrowhead). D.
Orthogonal confocal reconstruction of a z-stack showing co-localization of Sox-2 (red), BrdU (green) and GFAP (blue). Scale bar = 20 mm.
Abbreviations: calretinin: CR; glial fibrillary acidic protein: GFAP; tyrosine hydroxylase: TH.
doi:10.1371/journal.pone.0066377.g004
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Figure 5. Ultra-structural analysis of Sox-2 expression. A. Sox-2 immuno-gold label is observed in the nucleus (arrowheads) in ependymal
cells and astrocytes in ultra-thin sections of the SVZ. Boxed areas show an ependymal cell (E) and an astrocyte (As). Ependymal layer (EL), gap layer
(HL), astrocyte ribbon layer (R). Scale bar = 20 um; Scale bar in boxed areas = 1 um. a1. Magnification shows a Sox-2+ astrocyte and lack of
immunoreactivity in an oligodendrocyte (O) and a microglial cell (Mi). Astrocytes are recognized by the presence of dense bundles of intermediate
filaments (arrows). Scale bar = 2 um. B. Sox-2 immuno-gold staining in a group of neuroblasts (type A cells). Scale bar = 20 um. b1. Magnification of
three neuroblasts showing the nuclear staining. Neuroblasts form chain-like structures with characteristic intercellular spaces (arrows). Scale
bar = 2 um. C. Light microscopy image of a semi-thin section showing the distribution and characterization of cells expressing Sox-2 in the dentate
MPTP Modulates Neurogenesis in Primate Striatum
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by electrophoresis SDS-PAGE in a Bio-Rad Miniprotean III
electrophoresis unit. Subsequently, proteins were electrotrans-
ferred onto a polyvinylide fluoride sheets (PVDF) membrane (Bio-
Rad). Membranes were blocked with Tris-NaCl-Tween 20 (TNT)
with 5% non-fat milk for 1 hour at room temperature and
incubated with primary antibodies against TH (1/2000) (Milli-
pore) overnight at 4uC. After three washes of 10 min each in
TNT, membranes were incubated for 1 hour at room temperature
with a horseradish-peroxidase conjugated secondary antibody (GE
healthcare). Actin was employed as a control. Proteins were
detected by chemiluminescence using ECL reagent (Thermo
scientific) according to the manufacturer’s instructions on a Kodak
X-Omat film.
Schematic Drawings of Cell Distribution for Calretinin+/
Sox-2+ Double-labeled Cells and TH+ Cells
Tissue sections were examined under an Olympus BX-51
microscope hard-coupled to a DP70 camera and a computer
equipped with Olympus CAST system version 2.0 (Olympus,
Albertslund).
TH+ neurons in DAB stained preparations and double labeled
Calretinin+/Sox-2+ in double-immunofluroscence stained sections
were systematically sampled using a 606 lens (Plan Apo N 606/
1.42 oil, Olympus) and marked on the screen using the software
Olympus CAST system version 2.0 (Olympus, Albertslund). The
same sections were photomicrographed using a 46 lens (UPla-
nApo 46/0.16, Olympus) objective. The acquired images were
assembled in Adobe Photoshop CS to generate pictures of the
whole striatum. The contours and marks on all figures were drawn
using Macromedia FreeHand MXa.
Statistical Analysis
Given the small sample size, non-parametric tests were applied
and data are given as median and quartiles. For multiple
comparisons, a non-parametric Kruskal-Wallis test was used to
estimate the overall significance followed by a non-parametric
Mann-Whitney U test for independent groups with significance
defined as p#0.05.
Results
Localization and Characterization of Sox-2+ Cells in the
Intact Nigrostriatal System of Adult Primates
We first examined the presence of Sox-2+ cells in neurogenic
niches and in the nigrostriatal system (Fig. 1). Immunohistochem-
ical analysis revealed that, as previously described [34,35] Sox-2
nuclear immuno-reactivity was present in the SVZ and in the SGZ
of the dentate gyrus (Fig. 1A,C). In the SVZ, Sox-2+ cells were
mainly located in the ependymal layer and in the astrocytic ribbon
layer (cellular layer). In the dentate gyrus, Sox-2+ cells were
predominantly situated within the SGZ and there were some Sox-
2+ cells in the granular and molecular layers. Interestingly, we also
found that Sox-2+ cells were broadly distributed within the brain
parenchyma in non-neurogenic areas, including the striatum and
the SN (Fig. 1C). The specificity of the staining in these regions
was confirmed for both secondary antibodies (Fig. S1A). Like in
the neurogenic regions the Sox-2 staining was nuclear (Fig. S1B).
Outside the neurogenic niches, Sox-2+ cells were spread through-
out the parenchyma and therefore Sox-2+ cell density was
considerably lower in the striatum and the SN than in the SGZ
of the dentate gyrus (SGZ of the dentate gyrus: Q1:5715; median:
5898; Q3:6320 cells/mm2, vs SN: Q1:740; median: 783; Q3:862
cells/mm2, p = 0.05; striatum: Q1:424; median: 436; Q3:458
cells/mm2, p= 0.05). The density of Sox-2+ cells was significantly
higher in the SN than in the striatum (p= 0.05) (Fig. 1B and Fig.
S1C).
To evaluate the self-renewal capacity of Sox-2+ cells, we
administered BrdU to control animals and sacrificed them 3
months later (see methods for details) and analyzed the co-
localization of BrdU and Sox-2. We also examined the expression
of Ki-67 in Sox-2+ cells to determine their proliferative capacity.
As expected, we found double-labeled cells using both markers in
the SVZ and SGZ (Fig. 2 and data not shown). Consistent with the
expression of Sox-2 in stem cells and progenitors at different
maturation stages, in the SVZ there were Sox-2+ cells that
expressed DCX (Fig. 2) or GFAP (not shown). These cells were
also found in the SGZ (Fig. 2 and data not shown). The intensity of
Sox-2+ staining was weaker in the Sox-2+/DCX+ cells than in
adjacent Sox-2+ cells (progenitor cells and transit amplifying
progenitors) (Fig. S2A) [32].
Interestingly, we found Sox-2+ cells co-localized with BrdU
and/or Ki-67 (Fig. 3A, B and Fig. S2B,C) both in the SN and the
striatum of control animals, demonstrating that Sox-2+ cells in the
nigrostriatal system of the adult primate retain proliferative
capacity. Nearly all Sox-2+ cells were GFAP+ but some (less than
1%) did not express this marker (Fig. 3A, B). Indeed, we found that
in the striatum some Sox-2+ cells expressed the neuron-specific
calcium binding protein calretinin (CR) (Fig. 3B, 4A and Fig.
S3A). These Sox-2+/CR+ neurons were present throughout the
striatal parenchyma but were more frequently located close to the
dorsolateral border of the striatum (Fig. 4A). The majority of the
Sox-2+/CR+ cells had a characteristic morphology with few aspiny
processes and displayed a high intensity of CR staining (Fig. 4A
and Fig. S3A). Sox-2+/CR+ cells did never co-express GFAP;
there were Sox-2+ cells that expressed neither CR nor GFAP (Fig.
S3A,B). We also found that Sox-2+ cells did not express other
markers of mature neurons such as NeuN, GAD-67 or TH (Fig. 3A
and data not shown). As stated above, very few Sox-2+ were not
GFAP+ and even fewer were CR+. However, taking into account
the density of Sox-2+ cells and the large striatal volume, even a
small percentage may have functional relevance. Interestingly, we
did not find any Sox-2+/CR+ cells in the SN of control monkeys
(Fig. 3A). In the striatum TH+ intrinsic cells were also negative for
Sox-2. TH+ intrinsic cells were always BrdU– as described [19]
and CR+ cells were BrdU– (Fig. 4B). The vast majority of BrdU+ -
labeled striatal cells were Sox-2+, either BrdU+/Sox-2+/GFAP–
cells or BrdU+/Sox-2+/GFAP+ cells (Fig. 4C, D).
gyrus. Sox-2+ cells are visualized by the nuclear dark brown DAB precipitate. The section was counterstained with toluidine blue. The line marks the
boundary between the granular layer (GrL) and the hilus (H) where most labeled cells were located. Scale bar = 100 um. c1) Neurons in the granular
layer were not Sox-2+. Scale bar = 10 um; Insert = 1 um. D. Microphotograph of a striatal field of a control monkey showing a Sox-2+ astrocyte and
unlabeled neuron (Neu) and microglial cells (Mi). Scale bar = 5 um. d1. Boxed area of the astrocyte (As) nucleus shows the gold particles
(arrowheads). Scale bar = 1 um. E. A representative Sox-2+ neuron in the striatum of a control monkey. Scale bar = 2 um. e1. Boxed area shows
deposition of gold particles over the nucleus (arrowheads) close to a synapse (arrow), which identifies this cell as a neuron. Scale bar = 1 um. F. Sox-2+
astrocyte in the substantia nigra pars compacta. Scale bar = 10 mm. f1. Boxed area shows a dense bundle of intermediate filaments (arrows) that
characterizes astrocytes. Arrowheads indicate gold particles in the nucleus. Scale bar = 1 mm. Abbreviations: subventricular zone: (SVZ); 39, 39-
diaminobenzidine: (DAB).
doi:10.1371/journal.pone.0066377.g005
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To verify the identity of the cells that expressed Sox-2 outside
the neurogenic niches, we performed a detailed ultra-structural
study using Sox-2 immuno-gold (using the neurogenic niches as
reference). Sox-2 immuno-gold+ cells were identified by the
presence of an abundant precipitate of fine gold particles
distributed throughout the nuclear surface [38]. In the SVZ, both
type E (ependymal cells) and type B cells (astrocyte-like) (Fig. 5A),
were labeled for Sox-2. Type B cells are the progenitor cells
[41]and have thick bundles of intermediate filaments in addition to
glycogen granules, and dense bodies in the cytoplasm. These Sox-
2+ progenitors were found mainly at the astrocytic ribbon layer
(Fig. 5a1). Importantly, we also found migratory neuroblasts (type
A cells) labeled by Sox-2+ (Fig. 5B). These cells were mainly
located in the gap layer, had a fusiform shape and tended to form
chain-like structures with characteristic intercellular spaces
(Fig. 5B, 5b1). Using the same criteria in the SGZ of the dentate
gyrus, we determined that Sox-2 immuno-reactive cells corre-
sponded to the neural stem cells that share ultra-structural
characteristics with astrocytes (Fig. 5C, 5c1) i.e. type B cells in
the SVZ. These results corroborate that Sox-2 is expressed both by
neural progenitors and neuroblasts in the neurogenic niches.
Using the same strategy, we analyzed the nigrostriatal samples.
In the striatum, like in the neurogenic niches, the majority of the
Sox-2 immuno-gold+ cells corresponded to astrocytes (Fig. 5D,
5d1). Importantly, we also observed Sox-2+ neurons (Fig. 5E, 5e1).
These Sox-2+ cells were identified under the electron microscopy
as likely neurons by the presence of synaptic contacts that were
mostly symmetric and contained abundant pleomorphic vesicles
and large mitochondria (Fig. 5e1). In the SN, all the Sox-2+
immuno-gold+ cells had morphological characteristics of astrocytes
(Fig. 5F, 5f1) and we did not find any gold-labeled neurons. We
never found Sox-2 nuclear immuno-reactivity in oligodendrocytes
or microglial cells in any of the regions examined for this study
(Fig. 5D, 5E, 5F).
Effect of MPTP on the Sox-2+ Population of the
Nigrostriatal System
To investigate the effects of dopamine denervation on the Sox-
2+ cell population, we used MPTP administration and examined
the brains 3 months (short-term) and 18 months (long-term) after
the lesion. Quantification of TH+ neurons was performed on the
right SN and revealed a significant loss of dopamine neurons in all
MPTP-treated monkeys (Fig. 6A, B, C, D); control group:
Q1:129246; median: 130602; Q3:131175 TH+ neurons, vs. MPTP
short-term group: Q1:21913; median: 23367; Q3:51191 TH+
neurons, p= 0.034 and vs. MPTP long-term group: Q1:72495;
median: 81373; Q3:81395 TH+ neurons, p = 0.034. The loss of
nigral dopamine neurons was higher in the MPTP short-term
group (67%) than in the MPTP long-term group (40%), p= 0.043
(Fig. 6D). There was a relative preservation of the neuronal TH+
population of the ventral tegmental area (VTA) in both groups
(Fig. 6A, B, C). Since the loss of TH neurons was less severe in the
MPTP long-term animals than in the MPTP short-term animals
we evaluated the striatal levels of TH by western blot in all groups
(control group: Q1:0,801; median: 0,840; Q3:1,047 OD/mm2, vs.
MPTP short-term group: Q1:0,010; median: 0,012; Q3:0,148
OD/mm2, p= 0.034 and vs. MPTP long-term group: Q1:0,382;
median: 0,397; Q3:0,451 OD/mm2, p= 0.077. MPTP short-term
group vs. MPTP long-term group, p = 0.021) (Fig. 6I). These data
showed that the levels of TH were significantly lower in the short-
term animals suggesting that there was a partial recovery in the
long-term group. This is also consistent with the stereological
counts in the SN.
We found, as previously described [19,42]that MPTP-lesioned
animals showed a significant increase in the number of intrinsic
striatal TH+ neurons; control group: Q1:35; median: 44; Q3:48
(neurons/cm2) vs. MPTP short-term group: Q1:80; median: 84;
Q3:86 (neurons/cm2), p = 0.034 and vs. MPTP long-term group:
Q1:92; median: 104; Q3:105 (neurons/cm2), p = 0.034 (Fig. 6H).
However, the number of striatal TH+ neurons was not different
between the two groups of MPTP-monkeys (p = 0.083) (Fig. 6E,
e1, F, f1, G, g1, H). These data show that, in spite of the partial
compensation observed in TH levels, the increase in TH+ striatal
cells remained stable for the duration of the study (18 months).
The TH+ striatal neurons were distributed in a typical pattern [43]
being especially abundant in the rostro-dorsal region of the
caudate nucleus and putamen (Fig. S4A). The majority of TH+
cells were bipolar neurons with a round or oval perikaryon
[43,44].The distribution and the morphology were similar in
control and MPTP-lesioned animals (Fig. S4A).
The regional distribution of Sox-2+ cells was not different
between control and MPTP-treated animals, but the density of
Sox-2+ cells appeared to be higher in MPTP-treated animals as
compared with controls. Indeed, quantification of Sox-2+ cells
(Fig. 7) confirmed that, in the striatum, the density was higher in
the MPTP-treated groups than in controls (control group: Q1:424;
median: 436; Q3:458 cells/mm2, vs. MPTP short-term group:
Q1:756; median: 798; Q3:849 cells/mm2, p = 0.05; MPTP long-
term group: Q1:617; median: 645; Q3:720, p = 0.05). Both groups
of MPTP-monkeys exhibited similar density of striatal Sox-2+ cells
(Fig. 7A). In contrast, in the SN the density of Sox-2+ cells was
similar in the 3 groups (control group: Q1:740; median: 783;
Q3:862 cells/mm2, vs. MPTP short-term group: Q1:903; median:
915; Q3:1007 cells/mm2, p= 0.275 and vs. MPTP-long-term
group: Q1:840; median: 890; Q3:920 cells/mm2, p= 0.275;
MPTP short-term group vs. MPTP-long-term group, p = 1)
(Fig. 7A). We did not observe any differences between the controls
and the MPTP-treated animals regarding ultra-structural features
or phenotype of Sox-2+ cells. However, we found a significant
increase in the density of BrdU+/Sox-2+ cells in the MPTP-
lesioned animals (control group: Q1:1.01; median: 1.16; Q3:1.27
cells/mm2, vs. MPTP-short-term group Q1:3.40; median: 3.44;
Q3:4.20 cells/mm2, p = 0.034) (Fig. 7B) in the striatum.
As described above for control animals, in addition to astrocytes
there were Sox-2+/CR+ neurons in the striatum of the MPTP-
treated animals. Thus, to evaluate whether the neurogenic
Figure 6. MPTP effect on the nigrostriatal system. Midbrain sections at the level of the 3rd nerve from a control (A), a MPTP short-term (B) and
a MPTP long-term treated monkey (C) immunostained for TH. Note the severe reduction of TH immunoreactivity in the SNpc of the lesioned
monkeys. Scale bar = 1 cm. D. Stereological quantification of TH+ neurons in the SNpc. Data represent median and quartiles, N = 3, *p#0.05. Images
of precommisural striatum sections from a control monkey (E), a MPTP short-term monkey (F) and a MPTP long-term monkey (G) immunostained for
TH. Note the loss of TH+ fibers in the lesioned monkeys. Scale bar = 1 cm. Representative striatal sections of a control (e’) a MPTP short-term monkey
(f’) and a MPTP long-term monkey (g’), at higher magnification showing the intrinsic TH+ neurons (arrows). Scale bar = 300 mm. H. Quantification of
striatal TH+ neurons. There was a significant increase in the density of TH+ neurons after MPTP administration in both groups. Data represent median
and quartiles, N = 3, *p#0.05. I. Western blot to assess striatal TH levels showing a reduction in the MPTP-short term group and a partial recovery in
the MPTP-long term group with respect to controls. Data represent median and quartiles, N = 3, *p#0.05. Abbreviations: 1-methyl-4-phenyl-1,2,3,6
tetrahydropyridine: MPTP; tyrosine hydroxylase: TH; substantia nigra pars compacta: SNpc.
doi:10.1371/journal.pone.0066377.g006
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Figure 7. MPTP effect on Sox-2+ cells of the nigrostriatal system. A. Stereological estimation of Sox-2+ cells in the SNpc and the striatum of
the different groups of animals showed the significant increase of Sox-2+ cells in the striatum of MPTP-treated monkeys in both groups. Data
represent median and quartiles, N = 3, *p#0.05. B. There was an increase in the density of BrdU+/Sox-2+ cells in the MPTP-short-term group respect to
controls. Data represent median and quartiles, N = 3, *p#0.05. C. There were Sox-2+/CR+ cells both in control and in MPTP treated animals but
quantification showed a significant reduction of this population in the MPTP short-term group that was no longer present in the MPTP long-term
group Data represent median and quartiles, N = 3, *p#0.05. D. Schematic drawing of the distribution of CR+ cells in the MPTP treated animals. Note
that they show the same distribution as controls (see Fig. 4A) but the density appears lower in the short-term group. Abbreviations: substantia nigra
pars compacta: SNpc; 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine: MPTP; calretinin: CR.
doi:10.1371/journal.pone.0066377.g007
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potential of striatal Sox-2+ cells was changed by MPTP, we
quantified the percentage of striatal CR+ cells that co-expressed
Sox-2. We found that in the control group 11% of CR+ cells were
Sox-2+. Remarkably, the number of CR+/Sox-2+ cells was
significantly reduced in the MPTP short-term group (control
group: Q1:11; median: 12; Q3:12% vs. MPTP short-term group:
Q1:3.5; median: 4; Q3:4%, p= 0.05). In contrast, in the MPTP
long-term animals (examined 18 months after MPTP) the
percentage of CR+ that co-expressed Sox-2 was the same as in
control animals (MPTP long-term group: Q1:10.5; median: 11;
Q3:11%) (Fig. 7C). These results suggest that MPTP caused a
temporary disruption in the neurogenic capacity of Sox-2+ striatal
cells. As shown in Fig. 7D, the distribution of Sox-2+/CR+ neurons
was not changed (compare with Fig. 4A) in spite of the severe
reduction of this population in the short-term group. Note that the
distribution of Sox-2+/CR+ cells was remarkably similar to that
found for the TH+ cells that increase in the striatum after MPTP
administration (Fig. S4A).
Discussion
In this work we demonstrate that Sox-2+ cells with self-renewal
capacity are present in the striatum and the SN of the adult
primate brain. Importantly, although the majority of Sox-2+ cells
in the nigrostriatal system were GFAP+, we found that some Sox-
2+ cells were GFAP– (and may thus correspond to neural
amplifying progenitors, like in the SGZ). Furthermore, in the
striatum but not in the SN, we found that some CR+ neurons
expressed Sox-2, suggesting that there is a population of Sox-2+
striatal cells capable to differentiate into neurons in vivo in the adult
primate brain.
Sox-2 is essentially absent in mature neurons in the adult brain
[31,32]. Most Sox-2+ cells in the brain are astrocytes, which may
be similar to neural stem cells in terms of potentiality but
quiescent, and susceptible to be activated by injury or other stimuli
[45]. In adult tissues, stem cells are in different states of dormancy
and may have different roles in tissue homeostasis and regener-
ation. Sox-2 is present in stem cells and neural progenitors and is
important to inhibit cell cycle exit and neuronal maturation.
Nevertheless, it has been described [32] that in cells in the
germinal niches weak Sox-2 co-localizes with early neuronal
markers, indicating a concomitant appearance of neuronal
phenotypic markers, i.e. CR, with decreasing Sox-2 levels [46].
In contrast with a previous study in rodents [31], concluding that
Sox-2+ cells lack proliferative capacity outside the adult neuro-
genic niches, we found that Sox-2+ cells in the adult primate SN
and striatum retained mitotic capacity under baseline conditions.
This discrepancy is likely due to methodological differences in
BrdU administration and time of analyses. The analyses of BrdU
incorporation showed that Sox-2+ cells can self-renew and give rise
mainly to GFAP+ astrocytes. Sox-2+ cells in the nigrostriatal
regions were similar to those in the neurogenic niches of the SVZ
and SGZ, if considerably less abundant. This is consistent with
experiments performed in rodents, in which in cultures of an equal
mass of neurogenic and non-neurogenic areas of the adult brain,
neurogenic zones yield a higher proportion of progenitor-like
colonies [10]. Fate map analysis of Sox-2+ cells in the dentate
gyrus has revealed that non-radial Sox-2+ cells, are neural
progenitors with self- renewal potential that give rise to both
neurons and astrocytes [28](Fig. 8).
CR is a neuron-specific calcium binding protein that is
expressed in a subset of mature striatal interneurons [46].
However, it is worth noting that CR is also expressed in
neuroblasts and young neurons during embryonic development
[47] and in the adult neurogenic areas in hippocampus [48,49]
and rostral migratory stream [50]. In the DG, CR is regarded as a
transitional maturation marker for new granule cells (expressed
before they become calbindin+ neurons) [48,51,52]. We propose
here that striatal Sox-2+/CR+ cells are immature because Sox-2 is
still detectable. In the hippocampus and the SVZ weak immuno-
reactivity for Sox-2 coincides with expression of DCX and other
neuronal markers, strongly suggesting that there is an intermediate
stage in which young neurons co-express Sox-2 (going down) and a
neuronal marker (going up). In spite of several reports describing
newborn neurons in the striatum as CR+ interneurons [14,53], we
think that, given the transient character of CR expression during
various developmental and maturation stages, it is not possible to
establish whether the expression of CR in these neurons is
permanent or transient. Because complete maturation of neurons
requires down-regulation of Sox-2 [24,25] we can only speculate
about the final fate of these striatal newborn neurons. Therefore,
in our study we cannot determine whether CR indicates the final
phenotype of new striatal neurons, or a transient stage in
maturation (Figure 8B, C).
Interestingly, MPTP caused a marked increase in the number of
Sox-2+ cells in the striatum, but not in the SN, and an increase in
the amount of newly generated Sox-2+/BrdU+ striatal cells.
Previous studies in rodents have shown increased numbers of
neural progenitors in the striatum and midbrain after MPTP
administration [54,55]. However, while in the striatum the newly
generated cells persisted for a long period of time (as astrocytes), in
the SN the newborn cells maintained an undifferentiated
phenotype and showed short survival times [54,55]. We failed to
detect any increase in Sox-2+ cells in the SN, but cannot
completely rule out a transient increase of short-lived Sox-2+ cells
in the region– that were no longer present at the time of analysis (3
months after the MPTP administration). Taken together, our
results point out that MPTP, either directly or indirectly,
stimulates the renewal of Sox-2+ cells in the striatum and suggest
a different potential and/or reactivity of Sox-2+ cells in the two
regions. However, this can also be due to differences in the
microenvironment as both the direct consequences of the MPTP
lesion (most conspicuously the abrupt fall of dopamine levels in the
striatum) and perhaps some compensatory mechanisms, differ
between the two regions [54]. Indeed, dopamine has long been
implicated in the control of adult neurogenesis in the SVZ
[56,57,58].
Figure 8. Cell renewal and differentiation dynamics of progenitors in the striatum. Schematic representation of hypothetic dynamics of
endogenous striatal progenitors and the effects of MPTP. A. For reference we represented on top, the results of fate mapping of Sox-2+ cells in the
murine dentate gyrus showing that non-radial Sox-2+ progenitors have self-renew potential and give rise to both neurons and astrocytes [26]. B, C.
Similarly, we propose than in the normal situation, Sox-2+ striatal progenitors (Sox-2+/GFAP2/CR–) divide to generate new Sox-2+ progenitors.
Moreover, some Sox-2+ progenitors give rise to astrocytes and (few) Sox-2+/CR+ neurons that after several maturation steps could switch off Sox-2
expression and give rise to different mature phenotypes (including TH+). Following MPTP administration the number of Sox-2+ progenitors increases
while the number of CR+ cells that express Sox-2 is decreased. Possible mechanisms are A) MPTP favours gliogenesis from Sox2 progenitors at the
expense of neurogenesis. B) MPTP (or lack of dopamine) accelerates maturation of Sox-2+/CR+ cells. C) Sox-2+/CR+ cells are susceptible to MPTP
toxicity. Abbreviations: 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine: MPTP; calretinin: CR; tyrosine hydroxylase: TH.
doi:10.1371/journal.pone.0066377.g008
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In contrast with the reactive neurogenesis that has been shown
to occur in the primate sensorimotor system after injury [20] and
in the caudate nucleus and cortex after stroke [21], here we found
that MPTP markedly decreased the percentage of Sox-2+/CR+
cells in the striatum. Intriguingly, this effect was reversible and by
18 months there was a complete normalization of Sox-2+/CR+
numbers. It has been previously reported that aged monkeys
treated with MPTP showed, five weeks after the last injection, a
reduced formation of neuroblasts in the SVZ [57]. Therefore, it is
possible that the acute reduction in Sox-2+/CR+ striatal neurons
that we observed is a reflection of a more general effect on
neurogenesis by MPTP (or by the fall in dopamine levels).
Alternatively, we have to consider the possibility that Sox-2+/
CR+ cells are susceptible to the neurotoxic effects of MPTP.
Although a direct effect is unlikely, a decrease in growth factors or
morphogens locally released by dopamine axons could be involved
in this effect. Such an effect could explain the temporary reduction
in the percentage of Sox-2+/CR+3 months after MPTP.
Another tantalizing possibility (if speculative, at this time) is that
there is a link between the robust increase in TH+ intrinsic striatal
neurons and the decrease in Sox-2+/CR+cells. We have previously
reported that a proportion of striatal intrinsic TH+ neurons co-
express CR in the primate [44]. Sox-2+/CR+ cells could represent
an immature stage of this reactive population that appears rapidly
following dopamine lesions. Upon down-regulation of Sox-2, these
neurons would up-regulate TH (becoming CR+/TH+), and this
transition could be accelerated by the reduction of dopamine levels
caused by MPTP. This could account for both the increase in TH+
cells and the reduction in the percentage of Sox-2+/CR+ cells
shortly after MPTP administration. Once the dopamine levels are
partially restored and the insult is over, new Sox-2+/CR+ cells
would be generated from local Sox-2+ progenitors to restore the
pool of Sox-2+/CR+ cells that exists in physiological conditions
(Fig. 8). In the future, lineage-tracing experiments in the mouse
could help determine the relationship between both populations.
In any event, given their neurogenic capacity, reactivity and
plasticity after a neurotoxic insult in the primate, the striatal Sox-
2+ cells represent an attractive target for endogenous repair
strategies.
Notwithstanding, we have to point out several potential caveats
in our study. First, although BrdU is considered a reliable method
to identify newborn cells in the brain, there are few studies in
primates. We have chosen this regime of administration of BrdU
based on previous studies in the primate brain [6,36,37,59]
suggesting that the dose and time are sufficient to detect newborn
mature neurons in the dentate gyrus and neocortex. However, we
cannot rule out the possibility that more time is necessary to detect
newborn mature neurons originated in the striatum or migrating
from the SVZ. Moreover, Cameron and McKay (2001) [55],
systematically studied the effect of higher doses of BrdU in adult
rats. They found that doses up to 600 mg/kg did not have adverse
effects on either the animals or the labeled cells. Furthermore, the
number of BrdU-labeled cells in the dentate gyrus markedly
increased between doses of 50 mg/kg and 300 mg/kg. At the
higher dose they estimated that 9,000 new cells were added to the
dentate gyrus every day, most of which became neurons. Although
little is known about the similarity of rats and macaques regarding
the clearance of BrdU and the ability of BrdU to cross the blood-
brain barrier, these results raise the possibility that in our study we
underestimated the numbers of new adult-generated cells in the
macaque striatum.
Regarding the MPTP primate model, major limitations are the
toxic nature of the lesion, the lack of progression and the absence
of alpha-synuclein cytoplasmic inclusions [60].Therefore, the
compensatory or regenerative mechanisms induced by MPTP
can be radically different from those occurring in clinical
Parkinson’s disease. Nevertheless, in our paradigm (low-dose
repeated systemic administration of the toxin) both the loss of
dopamine neurons in the SN and the decrease in striatal dopamine
content are gradual, providing a closer approximation to
Parkinson’s disease progressive features [61]. Our data cannot
indicate whether neurogenesis takes place in the human striatum
but our findings showing a unique temporal response of the striatal
Sox-2+/CR+ population in MPTP-treated monkeys merit further
investigation.
Finally, both Sox-2 and CR expression are dynamically
regulated during developmental and adult neurogenesis
[24,25,48,49,50,52]. This further increases the complexity of the
analyses of their respective progenies. For this reason, we have
proposed alternative models that fit our results, understanding that
our data alone cannot determine the final destiny of these
populations (that will require fate-mapping experiments).
In conclusion, we demonstrate here that progenitor cells with
neurogenic and proliferative potential persist in the normal adult
primate striatum. The response of this population to an injury
suggests that they are amenable to extrinsic manipulation and
therefore good candidates for regenerative and repair therapies.
Elucidating the signals and factors that regulate fate decisions in
Sox-2+ striatal progenitor cells can pave the way for endogenous
restoration of dopamine transmission in Parkinson’s disease.
Supporting Information
Figure S1 A. Confocal images showing no staining for Sox-2 in
absence of the primary antibody against Sox-2 (negative control of
Sox-2 staining). Scale bar = 20 mm. B. Confocal images and an
orthogonal confocal reconstruction of a z-stack showing nuclear
localization of Sox-2 in the SN (the same nuclear staining was
found in the striatum and in neurogenic niches). Scale
bar = 100 mm. C. To corroborate the density of Sox-2+ cells
obtained by stereology in the SN, we counted the number of Sox-
2+ cells in LSM frames (225 mm6225 mm) using ImageJ software.
A representative image is shown with 39 markers in
0.050625 mm2 which is roughly equivalent to our results (770/
mm2) using more precise stereological methods. Scale
bar = 20 mm.
(TIF)
Figure S2 A. Double immunofluorescence images showing
some Sox-2+/DCX+ cells in the SVZ. Note the weaker staining
of Sox-2+/DCX+ cells comparing with other Sox-2+ cells of the
SVZ (stem cells and transit amplifying progenitors). Scale
bar = 20 mm. B, C Double immunofluorescence images and
orthogonal confocal reconstructions of z-stacks showing Sox-2+
cells positive for BrdU and Ki-67. The images shown were taken
from the SN. Equal results were obtained from double-labeled
cells in the striatum (not shown). Scale bar = 10 mm. Abbrevia-
tions: doublecortin: DCX.
(TIF)
Figure S3 A. Orthogonal confocal reconstruction of a z-stack
showing a CR+ striatal cell (green) co-localized with Sox-2 (red).
Separate channels are shown in Fig. 4A. Scale bar = 20 mm. B.
Triple immunofluorescence images showing that some Sox-2+ cells
were negative for GFAP and CR (blue arrowhead). Scale
bar = 20 mm. Abbreviations: calretinin: CR; glial fibrillary acidic
protein: GFAP.
(TIF)
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Figure S4 A. Schematic drawing of the distribution of TH+
neurons in control animals. Note that they are located close to the
dorsolateral border of the striatum and the distribution is similar to
that of Sox-2+/CR+ cells. B. Orthogonal confocal reconstruction
of a z-stack showing a TH+ striatal cell (green) co-localized with
calretinin (CR) (red). Scale bar = 20 mm. Abbreviations: tyrosine
hydroxylase: TH; calretinin: CR.
(TIF)
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